Close Menu

NEW YORK (360Dx) – Roche today announced the cobas m 511 dedicated hematology testing solution has received CE marking, allowing it to be marketed in countries that recognize the designation. 

Roche is launching the integrated hematology analyzer, marking Roche Diagnostics' entry into the hematology market. 

According to the company, current hematology testing requires larger blood samples from patients, which then need to be run across several different systems. As a result, testing is labor and time intensive and can provide inconsistent results. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.